CA1198058A - Agent biostimulant - Google Patents

Agent biostimulant

Info

Publication number: CA1198058A
Authority: CA; Canada
Prior art keywords: lyophilized; inosite; creatine; magnesium salt; calcium
Prior art date: 1983-06-15
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired

Application number

CA000430431A

Other languages

English (en)

Inventor

Mihail S. Kirov

Pencho V. Burov

Ivan H. Kovachev

Ivan H. Radoslavov

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Pharmachim DSO

Original Assignee

Pharmachim DSO

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1983-06-15

Filing date

1983-06-15

Publication date

1985-12-17

1983-06-15 Application filed by Pharmachim DSO filed Critical Pharmachim DSO

1983-06-15 Priority to CA000430431A priority Critical patent/CA1198058A/fr

1985-12-17 Application granted granted Critical

1985-12-17 Publication of CA1198058A publication Critical patent/CA1198058A/fr

Status Expired legal-status Critical Current

Links

230000001764 biostimulatory effect Effects 0.000 title claims abstract description 15
CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 claims abstract description 22
NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims abstract description 18
239000003795 chemical substances by application Substances 0.000 claims abstract description 16
229960003624 creatine Drugs 0.000 claims abstract description 11
239000006046 creatine Substances 0.000 claims abstract description 11
QORVDGQLPPAFRS-XPSHAMGMSA-N galantamine hydrobromide Chemical compound Br.O1C(=C23)C(OC)=CC=C2CN(C)CC[C@]23[C@@H]1C[C@@H](O)C=C2 QORVDGQLPPAFRS-XPSHAMGMSA-N 0.000 claims abstract description 10
229960002024 galantamine hydrobromide Drugs 0.000 claims abstract description 10
229910000147 aluminium phosphate Inorganic materials 0.000 claims abstract description 9
CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims abstract description 9
229940109850 royal jelly Drugs 0.000 claims abstract description 9
CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims abstract description 9
108010009736 Protein Hydrolysates Proteins 0.000 claims abstract description 7
ZFXVRMSLJDYJCH-UHFFFAOYSA-N calcium magnesium Chemical compound [Mg].[Ca] ZFXVRMSLJDYJCH-UHFFFAOYSA-N 0.000 claims abstract description 7
239000003531 protein hydrolysate Substances 0.000 claims abstract description 6
239000000413 hydrolysate Substances 0.000 claims description 9
230000000694 effects Effects 0.000 abstract description 9
201000010099 disease Diseases 0.000 abstract description 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 2
230000005923 long-lasting effect Effects 0.000 abstract description 2
229960004838 phosphoric acid Drugs 0.000 abstract 2
235000011007 phosphoric acid Nutrition 0.000 abstract 2
FBEHFRAORPEGFH-UHFFFAOYSA-N Allyxycarb Chemical compound CNC(=O)OC1=CC(C)=C(N(CC=C)CC=C)C(C)=C1 FBEHFRAORPEGFH-UHFFFAOYSA-N 0.000 abstract 1
239000000126 substance Substances 0.000 description 7
210000000653 nervous system Anatomy 0.000 description 5
239000000203 mixture Substances 0.000 description 4
230000003387 muscular Effects 0.000 description 4
VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 3
238000002360 preparation method Methods 0.000 description 3
KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 3
235000020357 syrup Nutrition 0.000 description 3
VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 3
235000013343 vitamin Nutrition 0.000 description 3
239000011782 vitamin Substances 0.000 description 3
WIGIZIANZCJQQY-UHFFFAOYSA-N 4-ethyl-3-methyl-N-[2-[4-[[[(4-methylcyclohexyl)amino]-oxomethyl]sulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide Chemical compound O=C1C(CC)=C(C)CN1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCC(C)CC2)C=C1 WIGIZIANZCJQQY-UHFFFAOYSA-N 0.000 description 2
101100476962 Drosophila melanogaster Sirup gene Proteins 0.000 description 2
GZCGUPFRVQAUEE-SLPGGIOYSA-N aldehydo-D-glucose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-SLPGGIOYSA-N 0.000 description 2
239000002775 capsule Substances 0.000 description 2
239000013256 coordination polymer Substances 0.000 description 2
235000016623 Fragaria vesca Nutrition 0.000 description 1
240000009088 Fragaria x ananassa Species 0.000 description 1
235000011363 Fragaria x ananassa Nutrition 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
241000700159 Rattus Species 0.000 description 1
235000011034 Rubus glaucus Nutrition 0.000 description 1
244000235659 Rubus idaeus Species 0.000 description 1
235000009122 Rubus idaeus Nutrition 0.000 description 1
239000002253 acid Substances 0.000 description 1
235000001014 amino acid Nutrition 0.000 description 1
150000001413 amino acids Chemical class 0.000 description 1
239000008280 blood Substances 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
150000001669 calcium Chemical class 0.000 description 1
210000003169 central nervous system Anatomy 0.000 description 1
230000003247 decreasing effect Effects 0.000 description 1
230000007547 defect Effects 0.000 description 1
238000005553 drilling Methods 0.000 description 1
239000003814 drug Substances 0.000 description 1
235000013399 edible fruits Nutrition 0.000 description 1
230000003631 expected effect Effects 0.000 description 1
230000001939 inductive effect Effects 0.000 description 1
150000002500 ions Chemical class 0.000 description 1
LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
230000000813 microbial effect Effects 0.000 description 1
235000013336 milk Nutrition 0.000 description 1
239000008267 milk Substances 0.000 description 1
210000004080 milk Anatomy 0.000 description 1
210000004165 myocardium Anatomy 0.000 description 1
235000017807 phytochemicals Nutrition 0.000 description 1
229930000223 plant secondary metabolite Natural products 0.000 description 1
239000000843 powder Substances 0.000 description 1
230000009291 secondary effect Effects 0.000 description 1
239000011734 sodium Substances 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
230000004936 stimulating effect Effects 0.000 description 1
239000006188 syrup Substances 0.000 description 1
229940088594 vitamin Drugs 0.000 description 1
229930003231 vitamin Natural products 0.000 description 1

Landscapes

Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

CA000430431A 1983-06-15 1983-06-15 Agent biostimulant Expired CA1198058A (fr)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
CA000430431A CA1198058A (fr)	1983-06-15	1983-06-15	Agent biostimulant

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
CA000430431A CA1198058A (fr)	1983-06-15	1983-06-15	Agent biostimulant

Publications (1)

Publication Number	Publication Date
CA1198058A true CA1198058A (fr)	1985-12-17

Family

ID=4125484

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA000430431A Expired CA1198058A (fr)	1983-06-15	1983-06-15	Agent biostimulant

Country Status (1)

Country	Link
CA (1)	CA1198058A (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8603546B2 (en) *	1999-01-11	2013-12-10	Herbaceuticals Inc.	Herbal supplement for increased muscle strength and endurance for athletes

1983
- 1983-06-15 CA CA000430431A patent/CA1198058A/fr not_active Expired

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8603546B2 (en) *	1999-01-11	2013-12-10	Herbaceuticals Inc.	Herbal supplement for increased muscle strength and endurance for athletes

Similar Documents

Publication	Publication Date	Title
Naderi et al.	2016	Timing, optimal dose and intake duration of dietary supplements with evidence-based use in sports nutrition
Bohl et al.	2002	Magnesium and exercise
US4973467A (en)	1990-11-27	Dietary supplement for adults
US5716926A (en)	1998-02-10	Composition of pyruvate and protein and method for increasing protein concentration in a mammal
AU666654B2 (en)	1996-02-22	Calcium, trace mineral, vitamin D and drug therapy combinations
EP0669083B1 (fr)	1999-04-28	Boisson contenant de la créatine; procédé de préparation
US6221836B1 (en)	2001-04-24	Composition of pyruvate and anabolic protein and method for increasing fat loss in a mammal
CN102512655B (zh)	2013-10-30	左旋肉碱组合物和制剂，及其制备方法和应用
PT755633E (pt)	2000-04-28	Preparacao bifasica
EP1083915B1 (fr)	2007-02-28	Compositions contenant du molybdene destine a favoriser l'anabolisme des proteines et la detoxication
CN102949710A (zh)	2013-03-06	增加骨密度的药物组合物或保健品及其制备方法
US6008252A (en)	1999-12-28	Method for increasing muscle mass in a mammal
US4980168A (en)	1990-12-25	Dietary supplement for children
CN107455625A (zh)	2017-12-12	一种具有抗疲劳减肥功能的植物营养素饮料及其制备工艺
US6465018B1 (en)	2002-10-15	Dietary supplement for increasing energy, strength, and immune function
KR19990035872A (ko)	1999-05-25	체지방률을 낮추고 체조성을 개선시키는 식품 조성물 및 체지방률을 낮추고 체조성을 개선시키는 방법
CA1198058A (fr)	1985-12-17	Agent biostimulant
JP3622985B2 (ja)	2005-02-23	マグネシウム吸収を高め、アテローム性動脈硬化症を防ぐ方法
NO832057L (no)	1983-12-12	Biostimulerende middel
Pasquariello Jr et al.	1977	Benign increased intracranial hypertension due to chronic vitamin A overdosage in a 26-month-old child: the increased intracranial pressure subsided promptly with steroid therapy and cessation of vitamin A
CN102579956B (zh)	2013-10-23	一种药物组合物及其应用
RU2176893C2 (ru)	2001-12-20	БИОЛОГИЧЕСКИ АКТИВНАЯ ДОБАВКА К ПИЩЕ "ДНКаВИТ"
CN105581331B (zh)	2018-08-24	一种补钙营养组合物
US4696919A (en)	1987-09-29	Method of preventing and treating obesity
CA2082275A1 (fr)	1991-11-11	Composition pharmaceutique

Legal Events

Date	Code	Title	Description
2002-12-18	MKEC	Expiry (correction)
2003-06-15	MKEX	Expiry